LOS ANGELES – A cancer researcher at Childrens Hospital Los Angeles was awarded a $2.5 million grant to develop new treatments for leukemia in children.

Dr. Fatih Uckun of the CHLA’s Saban Research Institute received the grant from the National Cancer Institute for development of drugs used to fight acute lymphoblastic leukemia, the most common form of cancer in children and adolescents, according to hospital spokeswoman Ellin Kavanagh.

Uckun and his colleagues focus on medicines that specifically target leukemia cells.

“Our long-term goal is to translate recent research discoveries in nanotechnology and biotherapy into effective patient-tailored treatment programs for the most common form of childhood cancer,” said Uckun, who is also a professor of research pediatrics at the Keck School of Medicine at the University of Southern California.

The work will be accomplished in tandem with other member institutions of the NCI Alliance for Nanotechnology in Cancer.